John Couling - Nov 22, 2024 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
SVP, Entertainment
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling
Stock symbol
DLB
Transactions as of
Nov 22, 2024
Transactions value $
-$2,270,500
Form type
4
Date filed
11/26/2024, 06:42 PM
Previous filing
Feb 12, 2024
Next filing
Dec 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$162K -2K -1.84% $81.00 107K Nov 22, 2024 Direct F1, F2
transaction DLB Class A Common Stock Options Exercise $1.33M +40K +37.45% $33.15 147K Nov 22, 2024 Direct F1
transaction DLB Class A Common Stock Options Exercise $517K +8K +5.45% $64.60 155K Nov 22, 2024 Direct F1
transaction DLB Class A Common Stock Sale -$3.84M -48K -31.01% $80.00 107K Nov 22, 2024 Direct F1
transaction DLB Class A Common Stock Options Exercise $452K +7K +6.55% $64.60 114K Nov 25, 2024 Direct F1
transaction DLB Class A Common Stock Sale -$564K -7K -6.15% $80.50 107K Nov 25, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -40K -100% $0.00 0 Nov 22, 2024 Class A Common Stock 40K $33.15 Direct F3
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -8K -53.33% $0.00 7K Nov 22, 2024 Class A Common Stock 8K $64.60 Direct F4
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -7K -100% $0.00 0 Nov 25, 2024 Class A Common Stock 7K $64.60 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2 Shares include 239 shares and 48 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024 and November 15, 2024, respectively.
F3 This option was granted for a total of 40,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
F4 This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 75% of target, or 15,000 shares.